Lakefront Biotherapeutics/€LKFT

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Lakefront Biotherapeutics

Galapagos NV, abbreviated as GLPG on stock exchanges, is a global biotechnology firm specializing in the discovery and development of small molecule medicines. The company focuses on innovating treatments primarily in the fields of immunology and oncology. Founded in 1999, Galapagos operates out of its headquarters in Belgium and extends its reach across Europe and the United States, aiming to provide transformative therapies for significant unmet medical needs.
Ticker
€LKFT
Sector
Health
Primary listing
AEX
Employees
452
Headquarters
Mechelen, Belgium
Website
lakefrontbio.com

LKFT Metrics

BasicAdvanced
€1.6bn
2.75
€9.02
0.11
-

What the Analysts think about LKFT

Analyst ratings (Buy, Hold, Sell) for Lakefront Biotherapeutics stock.

LKFT Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

LKFT Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.